| scholarly article | Q13442814 |
| P50 | author | Roberto Romero | Q42734915 |
| Edi Vaisbuch | Q47805338 | ||
| P2093 | author name string | S K Kim | |
| O Erez | |||
| N G Than | |||
| Y Sorokin | |||
| J P Kusanovic | |||
| F Gotsch | |||
| P Mittal | |||
| S Mazaki-Tovi | |||
| S S Hassan | |||
| L Yeo | |||
| T Chaiworapongsa | |||
| P2860 | cites work | Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3 | Q24304467 |
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression | Q28573546 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion | Q33316902 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor | Q36360704 | ||
| Uterine artery Doppler in the prediction of adverse pregnancy outcome | Q36758150 | ||
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma | Q36984261 | ||
| Endoglin in angiogenesis and vascular diseases | Q37088038 | ||
| Hypertensive disorders of pregnancy: the United States perspective | Q37128585 | ||
| Twin-to-twin transfusion syndrome: an antiangiogenic state? | Q37183878 | ||
| The two stage model of preeclampsia: variations on the theme | Q37187589 | ||
| Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats | Q37449704 | ||
| Toxemia: new concepts in an old disease | Q39559348 | ||
| Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction | Q40238276 | ||
| Placental cytokines and the pathogenesis of preeclampsia | Q41452017 | ||
| Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24-42 weeks of gestation | Q41586305 | ||
| Placental bed spiral arteries in the hypertensive disorders of pregnancy | Q44053736 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| The frequency and severity of placental findings in women with preeclampsia are gestational age dependent | Q47414750 | ||
| Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award | Q48348609 | ||
| Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. | Q50734891 | ||
| Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. | Q51865183 | ||
| Unexplained fetal death: another anti-angiogenic state. | Q51909063 | ||
| Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. | Q52237839 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. | Q54283587 | ||
| Placental stress and pre-eclampsia: a revised view. | Q54774592 | ||
| A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation | Q56444585 | ||
| Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction | Q57316953 | ||
| Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction | Q58623928 | ||
| A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne's syndrome) | Q58778278 | ||
| Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia | Q58778301 | ||
| The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation | Q61845344 | ||
| Early and Late Preeclampsia | Q61853974 | ||
| Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia | Q64377002 | ||
| Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency | Q68013154 | ||
| Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses | Q68533648 | ||
| Fetal umbilical artery velocity waveforms and subsequent neonatal outcome | Q70153609 | ||
| A United States national reference for fetal growth | Q70895060 | ||
| Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation | Q72634270 | ||
| Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro | Q73314016 | ||
| Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group | Q73937666 | ||
| Activation of leukocytes during the uteroplacental passage in preeclampsia | Q77513220 | ||
| Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast | Q81086992 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia | Q81931104 | ||
| Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation | Q82054283 | ||
| Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction | Q83212134 | ||
| P433 | issue | 2 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | 155-162 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations | |
| P478 | volume | 35 |
| Q47162116 | Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. |
| Q35104545 | Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia |
| Q34037890 | Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction |
| Q43600447 | Clinical significance of soluble-endoglin levels in systemic lupus erythematosus: possible association with anti-phospholipid syndrome |
| Q61844895 | ELABELA plasma concentrations are increased in women with late-onset preeclampsia |
| Q35547367 | Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes |
| Q34119241 | Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia |
| Q37612429 | Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death |
| Q35362708 | Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice |
| Q34505704 | In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy |
| Q58795465 | Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia |
| Q36107337 | Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion |
| Q36062460 | Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia |
| Q34619975 | Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. |
| Q55004295 | Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. |
| Q40367971 | Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study |
| Q34119026 | Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study |
| Q33650241 | Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia |
| Q36015615 | The "Great Obstetrical Syndromes" are associated with disorders of deep placentation |
| Q64116833 | The Role of Placental Growth Factor, Soluble Endoglin, and Uterine Artery Diastolic Notch to Predict the Early Onset of Preeclampsia |
| Q34150192 | The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia |
| Q92515855 | The prediction of early preeclampsia: Results from a longitudinal proteomics study |
| Q38664824 | The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study |
| Q50102668 | The profiles of soluble adhesion molecules in the "great obstetrical syndromes". |
| Q49312791 | The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia |
Search more.